Estimated savings in medical costs when new oral anticoagulants are used for the treatment of patients with nonvalvular atrial fibrillation and venous thromboembolism vs. Warfarin in the u.s
Abstract
Authors
A. Amin A. Bruno J. Trocio J. Lin M. Lingohr-Smith